Tag : AI

Robotic surgery is rapidly reshaping the surgical landscape in Malaysia and across the region, offering patients shorter recovery times and improved outcomes. Yet its growing adoption raises critical questions of how best to train surgeons, credential practitioners, and prepare for the medico-legal implications that accompany new technologies. These pressing issues took center stage at the 2nd Picaso Robotic & MIS Exchange (PROMISE 2025), held from 26-28 September under the theme “A Milestone Event in Robotic & Minimally Invasive Surgery”. Organized under the leadership of Dr. Fam Xeng Inn (Organizing Chairman, PROMISE 2025), and endorsed by the College of Surgeons of Malaysia (Minimally Invasive Surgery Chapter), the Malaysian Urological Association, Hospital Canselor Tuanku Muhriz UKM, the Advanced MIS, Robotic & Ablation Society of Gynaecologists Malaysia (AMRAS), and the Malaysian Society of Colorectal Surgeons, the event brought together leading international surgeons from Malaysia, Singapore, Korea, China, the Philippines, Thailand, and the United States for live surgical demonstrations, didactic lectures, and interactive forums. The program showcased the breadth of robotic applications across urology, gynecology, colorectal, and general surgery, while also addressing key issues of safety, quality, and credentialing. During one of the featured panel discussions, experts called for the development of robust training, credentialing, and governance frameworks to match the pace of surgical innovation, ensuring that new technologies are adopted safely and sustainably.

In East Asia, nearly half of lung cancer patients are never-smokers. The LC-SHIELD study explores AI-driven nodule detection, showing feasibility and improved sensitivity and specificity for high-risk populations.

Psoriasis is a chronic inflammatory disorder characterized by systemic inflammation and elevated circulating levels of pro-inflammatory cytokines. This persistent inflammatory state has been implicated in immune-mediated injury across multiple organ systems, with particular involvement of renal tissues. However, few large-scale studies have evaluated whether psoriasis independently increases the risk of renal complications in type 2 diabetes mellitus (T2DM) patients receiving guideline-directed renoprotective therapies. A retrospective cohort study was performed by researchers in Texas to compare the risk of diabetic nephropathy, chronic kidney disease (CKD), end-stage renal disease (ESRD), and dialysis in T2DM patients with and without psoriasis who were receiving angiotensin-converting enzyme inhibitor (ACEI), angiotensin II receptor blocker (ARB) or sodium-glucose cotransporter-2 inhibitor (SGLT2i) therapies.